Globomycin

General Information


DRACP ID  DRACP04231

Peptide Name   Globomycin

Sequence  GXXXSX

Sequence Length  6

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C5H2N2

Absent amino acids  ACDEFHIKLMNPQRTVWY

Common amino acids  X

Mass  61944

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  0

Net charge  0

Boman Index  -246

Hydrophobicity  -20

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 17579235

Title  LspA-independent action of globomycin on Mycobacterium tuberculosis

Doi Not available

Year  2007

Literature 2

Pubmed ID 32768648

Title  Optimization of globomycin analogs as novel gram-negative antibiotics

Doi Not available

Year  2020

Literature 3

Pubmed ID 8875913

Title  Inhibition of spiralin processing by the lipopeptide antibiotic globomycin

Doi Not available

Year  1996

Literature 4

Pubmed ID 17101680

Title  Activities of antimicrobial peptides and synergy with enrofloxacin against Mycoplasma pulmonis

Doi Not available

Year  2007

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  18535

DRACP is developed by Dr.Zheng's team.